0.0134
+0.0009
+(7.20%)
At close: April 17 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 4 | 6 |
| Avg. Estimate | 14.92M | 14.92M | 88.07M | 66.03M |
| Low Estimate | 13.6M | 13.6M | 54.19M | 29.56M |
| High Estimate | 16.25M | 16.25M | 135.04M | 148.54M |
| Year Ago Sales | 32.74M | 20.51M | 168.07M | 88.07M |
| Sales Growth (year/est) | -54.42% | -27.23% | -47.60% | -25.03% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IMTXW | -- | -- | -- | -- |
| S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Related Tickers
GENFF Genflow Biosciences plc
0.0170
0.00%
WQ5.F Genflow Biosciences plc
0.0115
0.00%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0388
+83.89%
PTIXW Protagenic Therapeutics, Inc.
0.0045
-10.00%
ATNFW 180 Life Sciences Corp.
0.0079
+11.27%
KTTAW Pasithea Therapeutics Corp.
0.0199
+48.51%
GOVXW GeoVax Labs, Inc.
0.0331
0.00%
HUMAW Humacyte, Inc.
0.3970
+20.30%
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.0540
+42.11%
NYMXF Nymox Pharmaceutical Corporation
0.1364
+51.56%